Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Sirolimus (rapamycin) monotherapy prevents graft vascular disease in non-human primates. Dambrin, C., Klupp, J., Birsan, T., Luna, J., Suzuki, T., Kitamura, K., Staher, P., Fitzgerald, P., Jacobsen, W., Christians, U., Berry, G., Lam, T., Hausen, B., Hook, L., Morris, R. LIPPINCOTT WILLIAMS & WILKINS. 2001: 759–59
View details for Web of Science ID 000171895003542